Orrick Advises Solugen on $350 Million+ Series C Round

September.10.2021

Congratulations to our client Solugen, a Houston-based biotech startup, on its over $350 million Series C financing round. Led by Baillie Gifford and GIC, the round also included Temasek Holdings, funds and accounts managed by BlackRock, Carbon Direct Capital Management, Refactor Capital and Fifty Years.

The latest round of funding will be used to expand Solugen's Bioforge technology platform, which is used to produce lower-carbon and carbon-negative chemicals & materials for its customers, and to expand the company’s product portfolio.

The Orrick team advising Solugen was led by John Bautista and John Harrison and includes Montana Ware, Chapin Scaggs, Michael Yang, Ashley Walter, Beth Zane, Jeanine McGuinness, Hector Rodriguez, Dolph Hellman and Andrew Barlow.